| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.093 | 0.1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.061 | 0.1 |